🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Amgen reports Q1 2025 earnings: wwwext.amgen.com/newsroom/press… Safe Harbor: investors.amgen.com/forward-lookin… $AMGN

This #VAM2025, we’re proud to spotlight the Vasculitis Foundation’s Community Heroes ❤️ Their stories show the power of shared experience and the strength of the #vasculitis community. 🔗 Explore more here: amgen.ly/3GDEyPm

The introduction of biosimilars has already saved approximately $36 billion for the American health care system. Learn how the U.S. can further invest in biosimilar development to bolster health care sustainability: bit.ly/4jBCs1b @amgen sponsored content on @POLITICO.

#ICYMI: Murielle and her team shared new preclinical research in mice around blocking GIPR and activating GLP-1R. 🧬🔬 🔗Learn more in Nature Metabolism: communities.springernature.com/posts/gipr-ab-…

At the Milken Institute Global Conference panel, we discussed how AI, genetics & protein engineering are transforming drug discovery. From our research targeting Lp(a) to uncovering potentially protective mutations in obesity, we’re entering a new era of precision and

We’re honored to be recognized on Forbes’ 2025 list of America’s Best Large Employers. This recognition highlights what we strive for every day—which is delivering on our mission to serve patients and fight some of the world’s toughest diseases.

That’s a wrap! 🙌 The European Congress on Obesity gathered leading experts from around the world and organizations committed to improving the lives of people living with #obesity and related conditions– a mission we’re boldly dedicated to. #ECO2025 🔬🧬🤝

This #VAM2025, staying quiet isn’t an option. 🗣️ When it came to her care, Stacy didn’t wait for permission: she asked questions, pushed for answers, and built a care team that believed her. Her voice changed everything. Yours can too. Get inspired: amgen.com/stories/2025/0…

Now streaming! PsO Grateful Podcast Episode 2: Building PsOlidarity with your patients for Dermatology NPs and PAs. Hear seasoned PAs share strategies to foster open communication with patients about their plaque #psoriasis. Listen now: 🎙️amgen.ly/3YKPDV3 #PsOGrateful

At the Stanford Drug Discovery Symposium 2025, Amgen CEO Bob Bradway and EVP, R&D @JayBradner shared a compelling vision for the future of medicine. Swipe through our carousel for an exclusive look at what they had to say.

Behind Amgen’s smarter and faster clinical trials is our Center for Observational Research (CfOR). This #ClinicalTrialsDay, see how CfOR is helping bridge R&D – accelerating impact for patients. Thank you to patients, scientists, & those who drive clinical research. #CTD2025

@amgen is revealing the hidden impact of gout and putting it on full display in cities across the US. This May 22 on #GoutAwarenessDay, the truth will be uncovered. Learn more: goutrevealed.com #UncoverGout

🚨This #GoutAwarenessDay, we've unveiled murals in Atlanta, Charlotte, Dallas, and Phoenix to reveal the hidden impact of gout. Affecting 12M+ Americans, this serious condition is often misunderstood. #UncoverGout today to help raise awareness. 🔗 Learn more:

Living with #vasculitis? We’ve got you covered.❤️ The ANCA Resource Hub has what you need to track symptoms, prep for appointments and feel supported every step of the way. 🔗 Find clarity and support at every stage: amgen.ly/4j9JSrb #VAM2025

Research paves the way for new possibilities in cancer care, one discovery at a time. Amgen 🧪🔬🧬’s latest findings highlight: 🔬Innovative approaches for multiple cancer types 📊 New insights into targeted therapies 🌍 The global impact for patients Learn more at #ASCO25

May is #AsthmaAwarenessMonth 💙 Asthma often doesn’t occur alone. Many also live with CRSwNP, which can make care more complex. At Amgen, we’re advancing science to understand these connections and drive improved care. 🔗 Learn more: amgen.ly/45iGabN

🚀#DLL3 innovation brought us to new frontiers in small cell lung cancer care. Amgen 🧪🔬🧬’s T-cell engager technology is designed to activate the immune system to find & attack cancer cells that express DLL3. Discover how ⬇️ #ASCO25

🔬#SCLC NEWS: Late-breaking data at #ASCO25 highlights Amgen’s advances for people with small cell lung cancer. 🔗 Learn more: amgen.ly/3ZMDTlg $AMGN

LATTICE™ isn’t just talking progress in cardiovascular care—it’s helping define it. Catch highlights from the LATTICE™ #NLASessions presentation and hear from experts Andrew J Sauer MD, Nishant Shah, MD & Laney Jones, PharmD MPH on what’s driving change: amgen.ly/4kKSHZR